<DOC>
	<DOCNO>NCT02971150</DOCNO>
	<brief_summary>The purpose pilot study obtain information old Veterans ' preference treatment depression insomnia pilot test feasibility clinical effect Brief Behavioral Treatment Insomnia ( BBTI ) BBTI old Veterans live Treatment Resistant Depression ( TRD ) insomnia .</brief_summary>
	<brief_title>Treatment Resistant Depression Insomnia Older Veterans</brief_title>
	<detailed_description>Quantitative qualitative method use obtain information aid develop treatment approach appropriate old Veterans TRD insomnia . Qualitative data gather good understand Veterans ' preference treatment approach , particularly relate preference pharmacotherapy versus augmentation behavioral intervention BBTI . Using Randomized Controlled Trial ( RCT ) design , test whether augmentation BBTI acceptable old Veterans improve treatment response whose depression improve antidepressant pharmacotherapy alone assess association preference treatment response . Our aims hypothesis : Aim 1 : To characterize depression , insomnia , relevant clinical neuropsychiatric characteristic older Veterans TRD . H1a : In Veterans TRD , Antidepressant History Form ( ATHF ) score positive association Montgomery-Asberg Depression Rating scale ( MADRS ) score . H1b : In Veterans TRD , MADRS score positive association Insomnia Severity Index ( ISI ) score . Aim 2 : Perform qualitative interview old Veterans collect information view depression insomnia attitude preference treatment depression insomnia . Aim 3 : To examine feasibility use BBTI treat Veterans TRD insomnia . H3a : Use BBTI feasible old adult TRD define acceptability retention . Aim 4 : To determine antidepressant augmentation BBTI lead improvement score MADRS ISI scale old Veterans receive BBTI versus receive antidepressant optimization . H4a : Augmentation BBTI improve MADRS ISI score relative treatment antidepressant alone .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>Age ≥ 60 Diagnosis Major Depressive Disorder ( MDD ) Diagnosis Insomnia Disorder Must fail ≥ 1 antidepressant trial Lifetime/current Bipolar I/II diagnosis Lifetime/current Schizophrenia Spectrum Disorder diagnosis Substance Use Disorder within past 3 month High Suicide Risk safely manage Untreated Obstructive Sleep Apnea ( OSA ) Restless Legs Syndrome Rapid Eye Movement ( REM ) Sleep Behavior Disorder Active OR untreated Post Traumatic Stress Disorder ( PTSD )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>